Gold prices slip after rallying on Powell rate cut talk
Investing.com - Sophia Genetics reported on Tuesday third quarter earnings that matched analysts' forecasts and revenue that topped expectations.
Sophia Genetics announced earnings per share of $-0.36 on revenue of $11.6M. Analysts polled by Investing.com EPS of $-0.36 on revenue of $11.45M.
Sophia Genetics 's are down 20% and is trading at $2.10 , still down 88.54% from its 52 week high of $16.93 set on Monday, November 8, 2021.
Sophia Genetics shares gained 8.25% to trade at $2.10 in pre-market trade the report.
Sophia Genetics follows other major Healthcare sector earnings this month
Sophia Genetics's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar